Anti-CD47 Reference Antibody (ligufalimab)
- Product Code: 139896
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in cancer immunotherapy to block the CD47 protein on tumor cells, which helps the immune system, particularly macrophages, recognize and destroy cancer cells. It is being investigated in clinical trials for various hematologic malignancies and solid tumors, often in combination with other antibodies or therapies to enhance anti-tumor activity. Shows promise in promoting phagocytosis and activating adaptive immune responses against cancer.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-CD47 Reference Antibody (ligufalimab)
Used in cancer immunotherapy to block the CD47 protein on tumor cells, which helps the immune system, particularly macrophages, recognize and destroy cancer cells. It is being investigated in clinical trials for various hematologic malignancies and solid tumors, often in combination with other antibodies or therapies to enhance anti-tumor activity. Shows promise in promoting phagocytosis and activating adaptive immune responses against cancer.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :